Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cranford, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Citius Pharmaceuticals, Inc. has filed 629 SEC EDGAR filings since 23 Nov 2010

SEC filing history

Showing 76-100 of 629 matching filings.

Per page
25
Current page
4
4

4 filing

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
12 Nov 2024
Reporting date
11 Nov 2024
Next action
Verify source filing
4

4 filing

Filing date
27 Sep 2024
Reporting date
14 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Sep 2024
Reporting date
14 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
13 Sep 2024
Reporting date
09 Sep 2024
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
05 Sep 2024
Reporting date
05 Sep 2024
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Aug 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Aug 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
16 Aug 2024
Reporting date
12 Aug 2024
Next action
Verify source filing
SC 13D

SCHEDULE 13D

Filing date
16 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-41534

4 filing

Filing date
14 Aug 2024
Reporting date
12 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-41534

3 filing

Filing date
14 Aug 2024
Reporting date
12 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
12 Aug 2024
Reporting date
12 Aug 2024
Next action
Verify source filing
424B5 File 333-277319

PROSPECTUS SUPPLEMENT

Filing date
12 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
12 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
08 Aug 2024
Reporting date
08 Aug 2024
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
21 May 2024
Reporting date
21 May 2024
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
14 May 2024
Reporting date
14 May 2024
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
14 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .